Menu

• Ask a Health Expert about CARDIAC HYPERTROPHY
• Post Your Side Effect related to CARDIAC HYPERTROPHY
• CARDIAC HYPERTROPHY and FDA Warnings
• CARDIAC HYPERTROPHY in Patients Wiki
• Report CARDIAC HYPERTROPHY in Drug Side Effect Survey

CARDIAC HYPERTROPHY side effect

What is CARDIAC HYPERTROPHY ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Baraclude Side Effects Report #5668977-4
Health Professional from JAPAN reported BARACLUDE problem on Mar 12, 2008. Male patient, 49 years of age, was diagnosed with hepatitis b and was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: cardiac hypertrophy, chest discomfort, . BARACLUDE dosage: unknown. Patient recovered.

Methylprednisolo Side Effects Report #5689250-4
METHYLPREDNISOLONE SUCCINATEECTION problem was reported by a Consumer or non-health professional from CANADA on Mar 26, 2008. Male patient was diagnosed with graft versus host disease and was treated with METHYLPREDNISOLONE SUCCINATEECTION. After drug was administered, patient experienced the following problems/side effects: cardiac hypertrophy, . METHYLPREDNISOLONE SUCCINATEECTION dosage: CUMULATIVE 429.3 MG/KG. During the same period patient was treated with PREDNISONE. Patient died.

Methylprednisolo Side Effects Report #5689251-6
Consumer or non-health professional from CANADA reported METHYLPREDNISOLONE SUCCINATEECTION problem on Mar 26, 2008. Female patient was diagnosed with graft versus host disease and was treated with METHYLPREDNISOLONE SUCCINATEECTION. After drug was administered, patient experienced the following problems/side effects: cardiac hypertrophy, left ventricular dysfunction, scleroderma, . METHYLPREDNISOLONE SUCCINATEECTION dosage: CUMULATIVE 350.4 MG/KG. During the same period patient was treated with PREDNISONE. Patient recovered.

Methylprednisolo Side Effects Report #5689252-8
METHYLPREDNISOLONE SUCCINATEECTION problem was reported by a Consumer or non-health professional from CANADA on Mar 26, 2008. Female patient was diagnosed with graft versus host disease and was treated with METHYLPREDNISOLONE SUCCINATEECTION. After drug was administered, patient experienced the following problems/side effects: cardiac hypertrophy, . METHYLPREDNISOLONE SUCCINATEECTION dosage: CUMULATIVE 458.7 MG/KG. During the same period patient was treated with PREDNISONE. Patient recovered.


Methylprednisolo Side Effects Report #5689254-1
Consumer or non-health professional from CANADA reported METHYLPREDNISOLONE SUCCINATEECTION problem on Mar 26, 2008. Female patient was diagnosed with graft versus host disease and was treated with METHYLPREDNISOLONE SUCCINATEECTION. After drug was administered, patient experienced the following problems/side effects: cardiac hypertrophy, . METHYLPREDNISOLONE SUCCINATEECTION dosage: CUMULATIVE 336.9 MG/KG. During the same period patient was treated with PREDNISONE. Patient recovered.

Prograf Side Effects Report #5691608-4
PROGRAF problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 17, 2008. Female patient was diagnosed with renal and pancreas transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: cardiac hypertrophy, hepatic enzyme abnormal, ill-defined disorder, oedema peripheral, pulmonary hypertension, . PROGRAF dosage: 1 MG, BID; 0.5 MG, BID. During the same period patient was treated with PREDNISOLONE ACETATE, NAMENDA, LEVOXYL, CYTOMEL. Patient recovered.

Bevacizumab Side Effects Report #5624725-5
Consumer or non-health professional from UNITED KINGDOM reported BEVACIZUMAB problem on Jan 29, 2008. Male patient was diagnosed with colon cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: cardiac hypertrophy, interstitial lung disease, neuropathy peripheral, . BEVACIZUMAB dosage: 272 MG, Q2W. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, LEUCOVORIN CALCIUM, CINAL, DECADRON, ENSURE LIQUID, FERROMIA, HEPARIN. Patient was hospitalized. Patient recovered.

Triquilar Side Effects Report #5568214-5
TRIQUILAR problem was reported by a Health Professional from JAPAN on Dec 11, 2007. Female patient, 49 years of age, was diagnosed with oral contraception and was treated with TRIQUILAR. After drug was administered, patient experienced the following problems/side effects: cardiac hypertrophy, choking sensation, pulmonary hypertension, thrombosis, . TRIQUILAR dosage: unknown. Patient recovered.

Cyclophosphamide Side Effects Report #5527502-9
Health Professional from FRANCE reported CYCLOPHOSPHAMIDE problem on Nov 26, 2007. Female patient, 87 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: cardiac hypertrophy, ischaemic hepatitis, pleural effusion, pulmonary oedema, renal failure, . CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with DOXORUBICIN, VINCRISTINE SULPHATE, RITUXIMAB, PREDNISONE. Patient recovered.


Remicade Side Effects Report #5474425-X
REMICADE problem was reported by a Physician from JAPAN on Sept 21, 2007. Female patient, weighting 123.5 lb, was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: cardiac hypertrophy, . REMICADE dosage: unknown. Patient recovered.

Tacrolimus Side Effects Report #5482475-2
Physician from UNITED STATES reported TACROLIMUS problem on Oct 09, 2007. Female patient, weighting 135.4 lb, was diagnosed with prophylaxis against transplant rejection and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: cardiac hypertrophy, deep vein thrombosis, haemodialysis, haemoglobin decreased, hyperglycaemia, infection, platelet count decreased, pulmonary embolism, . TACROLIMUS dosage: unknown. During the same period patient was treated with PREDNISONE, MEROPENEM, MYCOPHENOLATE MOFETIL, METRONIDAZOLE, BACTRIM. Patient was hospitalized. Patient died on 05/05/2005.

Zonisamide Side Effects Report #5500192-7
ZONISAMIDE problem was reported by a Physician from JAPAN on Oct 17, 2007. Female patient, child 6 years of age, was diagnosed with epilepsy and was treated with ZONISAMIDE. After drug was administered, patient experienced the following problems/side effects: cardiac hypertrophy, cytomegalovirus infection, erythema infectiosum, hepatic function abnormal, human herpesvirus 6 infection, lymphocyte stimulation test positive, measles antibody positive, . ZONISAMIDE dosage: unknown. Patient was hospitalized. Patient died on 09/10/2007.

Baraclude Side Effects Report #5445022-7
Health Professional from JAPAN reported BARACLUDE problem on Sept 05, 2007. Male patient, 49 years of age, was diagnosed with hepatitis b and was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: cardiac hypertrophy, chest discomfort, . BARACLUDE dosage: unknown. Patient recovered.

Bevacizumab Side Effects Report #5403196-8
BEVACIZUMAB problem was reported by a Consumer or non-health professional from UNITED KINGDOM on July 17, 2007. Male patient was diagnosed with colon cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: cardiac hypertrophy, interstitial lung disease, neuropathy peripheral, . BEVACIZUMAB dosage: 272 MG, Q2W. During the same period patient was treated with LEUCOVORIN CALCIUM, OXALIPLATIN, FERROMIA, KYTRIL, HEPARIN, CINAL, ISODINE. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #5407084-2
Consumer or non-health professional from UNITED KINGDOM reported BEVACIZUMAB problem on July 23, 2007. Male patient was diagnosed with colon cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: cardiac hypertrophy, interstitial lung disease, neuropathy peripheral, . BEVACIZUMAB dosage: 272 MG, Q2W. During the same period patient was treated with LEUCOVORIN CALCIUM, OXALIPLATIN, FLUOROURACIL, FERROMIA, KYTRIL, HEPARIN, CINAL, ISODINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5389674-9
BEVACIZUMAB problem was reported by a Consumer or non-health professional from UNITED KINGDOM on July 02, 2007. Male patient was diagnosed with colon cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: cardiac hypertrophy, interstitial lung disease, neuropathy peripheral, . BEVACIZUMAB dosage: 272 MG, UNK. During the same period patient was treated with LEUCOVORIN CALCIUM, OXALIPLATIN, FLUOROURACIL, FERROMIA, KYTRIL, HEPARIN, CINAL, ISODINE. Patient was hospitalized. Patient recovered.

Actos Side Effects Report #5400078-2
Consumer or non-health professional from JAPAN reported ACTOS problem on July 13, 2007. Male patient, 53 years of age, was diagnosed with diabetes mellitus and was treated with ACTOS. After drug was administered, patient experienced the following problems/side effects: cardiac hypertrophy, face oedema, oedema peripheral, . ACTOS dosage: 15 MG (15 MG, 1 D). During the same period patient was treated with OLMESARTAN MEDOXOMIL, SEIBULE, NORVASC. Patient recovered.

Bevacizumab Side Effects Report #5389674-9
BEVACIZUMAB problem was reported by a Consumer or non-health professional from UNITED KINGDOM on July 02, 2007. Male patient was diagnosed with colon cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: cardiac hypertrophy, interstitial lung disease, neuropathy peripheral, . BEVACIZUMAB dosage: 272 MG, UNK. During the same period patient was treated with LEUCOVORIN CALCIUM, OXALIPLATIN, FLUOROURACIL, FERROMIA, KYTRIL, HEPARIN, CINAL, ISODINE. Patient was hospitalized. Patient recovered.

Actos Side Effects Report #5400078-2
Consumer or non-health professional from JAPAN reported ACTOS problem on July 13, 2007. Male patient, 53 years of age, was diagnosed with diabetes mellitus and was treated with ACTOS. After drug was administered, patient experienced the following problems/side effects: cardiac hypertrophy, face oedema, oedema peripheral, . ACTOS dosage: 15 MG (15 MG, 1 D). During the same period patient was treated with OLMESARTAN MEDOXOMIL, SEIBULE, NORVASC. Patient recovered.


Xalatan Side Effects Report #5759020-7
XALATAN problem was reported by a Physician from JAPAN on May 30, 2008. Male patient, 63 years of age, was diagnosed with glaucoma and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: cardiac hypertrophy, dysphonia, dyspnoea, palpitations, . XALATAN dosage: unknown. Patient recovered.

Myozyme Side Effects Report #5768470-4
Physician from ISRAEL reported MYOZYME problem on June 03, 2008. Male patient was diagnosed with glycogen storage disease type ii and was treated with MYOZYME. After drug was administered, patient experienced the following problems/side effects: cardiac hypertrophy, central line infection, cyanosis, deafness neurosensory, disease progression, electromyogram abnormal, hypotension, hypotonia, . MYOZYME dosage: unknown. During the same period patient was treated with CORTICOSTEROIDS, PHENERGAN, HYDROCORTISONE. Patient was hospitalized and became disabled. Patient recovered.

Cabaser Side Effects Report #5788261-8
CABASER problem was reported by a Pharmacist from JAPAN on June 13, 2008. Female patient, 65 years of age, was diagnosed with parkinson's disease and was treated with CABASER. After drug was administered, patient experienced the following problems/side effects: cardiac hypertrophy, cardiac valve disease, . CABASER dosage: unknown. Patient recovered.

Methylprednisolo Side Effects Report #5788816-0
Health Professional from CANADA reported METHYLPREDNISOLONE problem on June 17, 2008. Female patient was diagnosed with prophylaxis against graft versus host disease and was treated with METHYLPREDNISOLONE. After drug was administered, patient experienced the following problems/side effects: cardiac hypertrophy, left ventricle outflow tract obstruction, . METHYLPREDNISOLONE dosage: 350.4 MG/KG, TOTAL. During the same period patient was treated with PREDNISONE, CYCLOSPORINE. Patient recovered.

Methylprednisolo Side Effects Report #5788817-2
METHYLPREDNISOLONE problem was reported by a Health Professional from CANADA on June 17, 2008. Female patient was diagnosed with prophylaxis against graft versus host disease and was treated with METHYLPREDNISOLONE. After drug was administered, patient experienced the following problems/side effects: cardiac hypertrophy, . METHYLPREDNISOLONE dosage: 429.3 MG/KG, TOTAL. During the same period patient was treated with PREDNISONE, CYCLOSPORINE, AMLODIPINE, NADOLOL. Patient recovered.

Methylprednisolo Side Effects Report #5788835-4
Health Professional from CANADA reported METHYLPREDNISOLONE problem on June 17, 2008. Female patient was diagnosed with prophylaxis against graft versus host disease and was treated with METHYLPREDNISOLONE. After drug was administered, patient experienced the following problems/side effects: cardiac hypertrophy, . METHYLPREDNISOLONE dosage: 458.7 MG/KG, TOTAL. During the same period patient was treated with PREDNISONE. Patient recovered.

Methylprednisolo Side Effects Report #5788836-6
METHYLPREDNISOLONE problem was reported by a Physician from CANADA on June 17, 2008. Female patient was diagnosed with prophylaxis against graft versus host disease and was treated with METHYLPREDNISOLONE. After drug was administered, patient experienced the following problems/side effects: cardiac hypertrophy, . METHYLPREDNISOLONE dosage: 429.3 MG/KG, TOTAL. During the same period patient was treated with PREDNISONE. Patient recovered.

Detrusitol Side Effects Report #5726831-3
Pharmacist from JAPAN reported DETRUSITOL problem on Apr 22, 2008. Female patient, 64 years of age, was treated with DETRUSITOL. After drug was administered, patient experienced the following problems/side effects: cardiac hypertrophy, . DETRUSITOL dosage: DAILY DOSE:4MG. During the same period patient was treated with CALBLOCK, NU LOTAN, MEVALOTIN, HOCHUUEKKITOU. Patient recovered.

Baraclude Side Effects Report #5726982-3
BARACLUDE problem was reported by a Health Professional from JAPAN on Apr 23, 2008. Male patient, 49 years of age, was diagnosed with hepatitis b and was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: cardiac hypertrophy, chest discomfort, . BARACLUDE dosage: unknown. Patient recovered.

Myozyme Side Effects Report #5729660-X
Physician from ISRAEL reported MYOZYME problem on Apr 21, 2008. Male patient was diagnosed with glycogen storage disease type ii and was treated with MYOZYME. After drug was administered, patient experienced the following problems/side effects: cardiac hypertrophy, central line infection, cyanosis, deafness neurosensory, disease progression, dysstasia, electromyogram abnormal, hypotension, . MYOZYME dosage: unknown. During the same period patient was treated with CORTICOSTEROIDS, PHENERGAN, HYDROCORTISONE. Patient was hospitalized and became disabled. Patient recovered.

Xalatan Side Effects Report #5746811-1
XALATAN problem was reported by a Pharmacist from JAPAN on May 12, 2008. Male patient, 63 years of age, was diagnosed with glaucoma and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: cardiac hypertrophy, dysphonia, dyspnoea, palpitations, . XALATAN dosage: unknown. Patient recovered.

Methylprednisolo Side Effects Report #5702942-3
Physician from CANADA reported METHYLPREDNISOLONE problem on Mar 27, 2008. Female patient was diagnosed with graft versus host disease and was treated with METHYLPREDNISOLONE. After drug was administered, patient experienced the following problems/side effects: cardiac hypertrophy, hypertension, ventricular hypertrophy, . METHYLPREDNISOLONE dosage: CUMULATIVE DOSE OF 336.9 MG/KG. During the same period patient was treated with CYCLOSPORINE, AMLODIPINE, NADOLOL, CAPTOPRIL. Patient recovered.

Detrusitol Side Effects Report #5718907-1
DETRUSITOL problem was reported by a Pharmacist from JAPAN on Apr 21, 2008. Female patient, 64 years of age, was treated with DETRUSITOL. After drug was administered, patient experienced the following problems/side effects: cardiac hypertrophy, . DETRUSITOL dosage: DAILY DOSE:4MG. During the same period patient was treated with CALBLOCK, NU LOTAN, MEVALOTIN, HOCHUUEKKITOU. Patient recovered.

Actos Side Effects Report #5719283-0
Consumer or non-health professional from JAPAN reported ACTOS problem on Apr 10, 2008. Male patient, 49 years of age, was diagnosed with diabetes mellitus and was treated with ACTOS. After drug was administered, patient experienced the following problems/side effects: cardiac hypertrophy, cardiac tamponade, chest pain, dyspnoea, electrocardiogram st-t change, face oedema, oedema peripheral, tachycardia, weight increased, . ACTOS dosage: 15 MG (15 MG, 1 D) PER ORAL; 30 MG (30 MG, 1 D) PER ORAL. During the same period patient was treated with MICARDIS. Patient was hospitalized. Patient recovered.

Prograf Side Effects Report #5725824-X
PROGRAF problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 18, 2008. Female patient was diagnosed with renal and pancreas transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: cardiac hypertrophy, hepatic enzyme increased, ill-defined disorder, oedema peripheral, portal vein pressure increased, pulmonary arterial hypertension, . PROGRAF dosage: 1 MG, BID ; 0.5 MG, BID. During the same period patient was treated with PREDNISOLONE ACETATE, NAMENDA, LEVOXYL, CYTOMEL. Patient recovered.

Ranexa Side Effects Report #5345132-9
Pharmacist from UNITED STATES reported RANEXA problem on May 18, 2007. Male patient, 69 years of age, was diagnosed with angina pectoris and was treated with RANEXA. After drug was administered, patient experienced the following problems/side effects: cardiac hypertrophy, coordination abnormal, neuropathy peripheral, renal failure acute, . RANEXA dosage: 500 MG, BID, ORAL. During the same period patient was treated with COLCHICINE, PROBENECID, ALLOPURINOL, ATENOLOL, PRAVACHOL, VITAMIN E, LISINOPRIL, AMITRIPTYLINE. Patient was hospitalized. Patient recovered.

Tramadol Side Effects Report #5360218-0
TRAMADOL HYDROCHLORIDE problem was reported by a Physician from UNITED STATES on June 04, 2007. Male patient, 42 years of age, weighting 288.8 lb, was treated with TRAMADOL HYDROCHLORIDE. After drug was administered, patient experienced the following problems/side effects: cardiac hypertrophy, cardiomegaly, completed suicide, coronary artery disease, coronary artery stenosis, false positive laboratory result, hepatic steatosis, hepatomegaly, . TRAMADOL HYDROCHLORIDE dosage: unknown. Patient died.

Rebif Side Effects Report #5371463-2
Consumer or non-health professional from UNITED STATES reported REBIF problem on June 14, 2007. Female patient, 42 years of age, weighting 180.0 lb, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: cardiac hypertrophy, cardiac murmur, chest discomfort, chest pain, hyperhidrosis, hypoaesthesia facial, nausea, . REBIF dosage: unknown. During the same period patient was treated with TOPROL, LIPITOR, HYDROCODONE. Patient was hospitalized. Patient recovered.

Ibuprofen Side Effects Report #5338211-3
IBUPROFEN problem was reported by a Physician from GERMANY on May 23, 2007. Female patient, weighting 6.28 lb, was treated with IBUPROFEN. After drug was administered, patient experienced the following problems/side effects: cardiac hypertrophy, ductus arteriosus premature closure, neonatal cardiac failure, premature baby, pulmonary valve incompetence, tricuspid valve incompetence, . IBUPROFEN dosage: unknown. Patient was hospitalized. Patient recovered.

Rebif Side Effects Report #5339962-7
Consumer or non-health professional from UNITED STATES reported REBIF problem on May 15, 2007. Female patient, 42 years of age, weighting 180.0 lb, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: cardiac hypertrophy, chest discomfort, chest pain, hyperhidrosis, hypoaesthesia facial, nausea, . REBIF dosage: unknown. During the same period patient was treated with TOPROL, LIPITOR, HYDROCODONE. Patient was hospitalized. Patient recovered.

Topamax Side Effects Report #5274267-4
TOPAMAX problem was reported by a Health Professional from UNITED STATES on Mar 12, 2007. Female patient, weighting 227.0 lb, was diagnosed with headache, benign intracranial hypertension, multiple sclerosis, muscle spasms, pain, insomnia, depression and was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: cardiac hypertrophy, diarrhoea, electrocardiogram qt prolonged, heart rate irregular, hypokalaemia, metabolic acidosis, polyuria, weight decreased, . TOPAMAX dosage: unknown. During the same period patient was treated with REBIF, BACLOFEN, IBUPROFEN, AMBIEN, LEXAPRO, DIAMOX. Patient recovered.

Parlodel Side Effects Report #5646669-5
Physician from JAPAN reported PARLODEL problem on Feb 27, 2008. Male patient, 43 years of age, was diagnosed with depression and was treated with PARLODEL. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive, cardiac hypertrophy, congestive cardiomyopathy, nasopharyngitis, pneumonia, . PARLODEL dosage: 2.5MG/DAY. During the same period patient was treated with ANAFRANIL, REQUIP, PAXIL, AKINETON. Patient was hospitalized. Patient recovered.

Avandia Side Effects Report #5669464-X
AVANDIA problem was reported by a Physician from EGYPT on Mar 12, 2008. Female patient, 75 years of age, was diagnosed with type 2 diabetes mellitus and was treated with AVANDIA. After drug was administered, patient experienced the following problems/side effects: anaemia, cardiac hypertrophy, . AVANDIA dosage: unknown. Patient recovered.

Avandia Side Effects Report #5675922-4
Physician from EGYPT reported AVANDIA problem on Mar 16, 2008. Female patient, 75 years of age, was diagnosed with hypersensitivity and was treated with AVANDIA. After drug was administered, patient experienced the following problems/side effects: anaemia, cardiac hypertrophy, dyspnoea, fluid retention, jugular vein distension, oedema peripheral, . AVANDIA dosage: unknown. Patient recovered.

Fabrazyme Side Effects Report #5689694-0
FABRAZYME problem was reported by a Physician from JAPAN on Mar 10, 2008. Male patient, 39 years of age, weighting 125.7 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, cardiac hypertrophy, disseminated intravascular coagulation, hepatic function abnormal, interstitial lung disease, multi-organ disorder, no therapeutic response, pneumonia, pulmonary haemorrhage, . FABRAZYME dosage: 55 MG, Q2W, INTRAVENOUS. During the same period patient was treated with CELESTAMINE, ETIZOLAM, FAMOTIDINE. Patient died on 07/28/2005.

Parlodel Side Effects Report #5630360-5
Physician from JAPAN reported PARLODEL problem on Feb 15, 2008. Male patient, 43 years of age, was diagnosed with depression and was treated with PARLODEL. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive, cardiac hypertrophy, congestive cardiomyopathy, hepatitis, . PARLODEL dosage: 2.5MG/DAY. During the same period patient was treated with ANAFRANIL, REQUIP, PAXIL, AKINETON. Patient was hospitalized. Patient recovered.

Gleevec Side Effects Report #5634561-1
GLEEVEC problem was reported by a Physician from JAPAN on Feb 12, 2008. Female patient, 83 years of age, was diagnosed with chronic myeloid leukaemia, blood pressure increased and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: brain natriuretic peptide increased, cardiac hypertrophy, cardiomegaly, dilatation ventricular, fall, fluid retention, haematocrit decreased, haemoglobin decreased, hypoventilation, . GLEEVEC dosage: 200MG / DAY. During the same period patient was treated with LASIX, DIOVAN. Patient recovered.

Citalopram Side Effects Report #5593349-0
Physician from UNITED KINGDOM reported CITALOPRAM HYDROBROMIDE problem on Dec 31, 2007. Female patient, 69 years of age, was diagnosed with major depression and was treated with CITALOPRAM HYDROBROMIDE. After drug was administered, patient experienced the following problems/side effects: benign neoplasm of thyroid gland, cardiac hypertrophy, contusion, excoriation, gastrointestinal disorder, scar, spinal osteoarthritis, . CITALOPRAM HYDROBROMIDE dosage: 40 MG;QD;PO. During the same period patient was treated with AMISULPRIDE, LISINOPRIL, SIMVASTATIN, BENDROFLUMETHIAZIDE, BISOPROLOL FUMARATE, LITHIUM CARBONATE. Patient died.

Paxil Side Effects Report #5501994-3
PAXIL problem was reported by a Physician from JAPAN on Oct 23, 2007. Female patient, weighting 7.50 lb, was diagnosed with dysthymic disorder and was treated with PAXIL. After drug was administered, patient experienced the following problems/side effects: caesarean section, cardiac hypertrophy, congenital anomaly, ventricular septal defect, . PAXIL dosage: 10MG SEE TEXT. During the same period patient was treated with NORITREN, LEVOTOMIN, SOLANAX, SEPAZON, SILECE, HALCION, VEGETAMIN A, PROMETHAZINE. Patient was hospitalized. Patient recovered.

Viagra Side Effects Report #5457766-1
Consumer or non-health professional from DENMARK reported VIAGRA problem on Sept 06, 2007. Male patient, 41 years of age, was diagnosed with erectile dysfunction and was treated with VIAGRA. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase mb increased, cardiac hypertrophy, restrictive cardiomyopathy, syncope, troponin t increased, ventricular tachycardia, . VIAGRA dosage: unknown. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5393009-5
MEMANTINE problem was reported by a Consumer or non-health professional from UNITED STATES on July 06, 2007. Male patient, 62 years of age, was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: arteriosclerosis, cardiac hypertrophy, cerebral atrophy, homicide, poisoning, unresponsive to stimuli, . MEMANTINE dosage: 10 MG BID. During the same period patient was treated with DONEPEZIL, CLONAZEPAM, PROPOXYPHENE HYDROCHLORIDE, ACETAMINOPHEN, VENLAFAXINE. Patient died.

Memantine Side Effects Report #5393009-5
Consumer or non-health professional from UNITED STATES reported MEMANTINE problem on July 06, 2007. Male patient, 62 years of age, was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: arteriosclerosis, cardiac hypertrophy, cerebral atrophy, homicide, poisoning, unresponsive to stimuli, . MEMANTINE dosage: 10 MG BID. During the same period patient was treated with DONEPEZIL, CLONAZEPAM, PROPOXYPHENE HYDROCHLORIDE, ACETAMINOPHEN, VENLAFAXINE. Patient died.